Devenport

Samantha Devenport, Ph.D.

Associate
Boston

I tailor my advice to my life sciences clients to match their business goals.

Dr. Samantha "Sammi" Devenport practices within the life sciences and pharmaceutical fields. She has a technical focus on cancer biology, cell biology, next-generation sequencing, gene editing techniques (CRISPR), flow cytometry, single cell sequencing, animal models and organoid models.

Sammi has a PhD from the University of Michigan in molecular and cellular biology. She has published a number of peer-reviewed articles, including publications in Nature Communications and Gastroenterology.
 

Education

  • Suffolk University School of Law, J.D., 2025
  • University of Michigan, Ph.D., Molecular and Cellular Biology
  • The Ohio State University, B.S., Biology/Biological Sciences, with research distinction in biology, cum laude

Experience

  • Practices within the life sciences and pharmaceutical fields with startup and large biotech companies, collaborating closely with scientific teams and in-house counsel to align patent strategy with broader business objectives.
  • Collaborates on building and managing global patent portfolios across cutting-edge therapeutic modalities, including cancer biology, cell biology, RNA-based therapies, monoclonal and engineered antibody therapies, CAR T cell technology, gene editing techniques such as CRISPR, single-cell sequencing, and viral vector therapies. 
  • Conducts patent-landscape and freedom-to-operate analyses that inform competitive positioning and guide research, development, and commercialization decisions. 

Honors & Involvement

INVOLVEMENT
  • Boston Patent Law Association
  • American Intellectual Property Law Association
  • Intellectual Property Owners Association
  • Foley Hoag Women Associates Affinity Group, Co-Chair